M. Castro, M. Kraft, C. Ambrose, N. Martin, N. Clarke, J. Spahn, J. Llanos, S. Ponnarambil
{"title":"Tezepelumab减少严重、不受控制哮喘患者的咳嗽和痰的产生:来自3期NAVIGATOR研究的结果","authors":"M. Castro, M. Kraft, C. Ambrose, N. Martin, N. Clarke, J. Spahn, J. Llanos, S. Ponnarambil","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4752","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"316 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Tezepelumab Reduces Patient-reported Cough and Phlegm Production in Patients With Severe, Uncontrolled Asthma: Results From the Phase 3 NAVIGATOR Study\",\"authors\":\"M. Castro, M. Kraft, C. Ambrose, N. Martin, N. Clarke, J. Spahn, J. Llanos, S. Ponnarambil\",\"doi\":\"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4752\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":222112,\"journal\":{\"name\":\"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD\",\"volume\":\"316 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4752\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4752","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Tezepelumab Reduces Patient-reported Cough and Phlegm Production in Patients With Severe, Uncontrolled Asthma: Results From the Phase 3 NAVIGATOR Study